Noninvasive assessment of tumor hypoxia with 99mTc labeled metronidazole.

This publication has 18 references indexed in Scilit:

• Fluorine-18 fluoromisonidazole tumour to muscle retention ratio for the detection of hypoxia in nasopharyngeal carcinoma
  European Journal of Nuclear Medicine and Molecular Imaging, 1996
• Pretreatment oxygenation predicts radiation response in advanced squamous cell carcinoma of the head and neck
  Radiotherapy and Oncology, 1996
• Development of new markers for hypoxic cells:¹³¹I]Iodomisonidazole and [¹³¹I]Iodoerythronitroimidazole
  Journal of Drug Targeting, 1996
• Usefulness of 99Tcm-N,N′-ethylene-l-dicysteine complex for dynamic kidney investigations
  Nuclear Medicine Communications, 1994
• Hypoxia-selective antitumor agents. 8. Bis(nitroimidazolyl)alkanecarboxamides: a new class of hypoxia-selective cytotoxins and hypoxic cell radiosensitizers
  Journal of Medicinal Chemistry, 1994
• Imaging of hypoxia in human tumors with [F-18]fluoromisonidazole
  International Journal of Radiation Oncology*Biology*Physics, 1992
• A review of hypoxic cell radiosensitization
  International Journal of Radiation Oncology*Biology*Physics, 1991
• Radiolabeled fluoromisonidazole as an imaging agent for tumor hypoxia
  Published by Elsevier ,1989
• Oxygen distribution in squamous cell carcinoma metastases and its relationship to outcome of radiation therapy
  International Journal of Radiation Oncology*Biology*Physics, 1988
• The Concentration of Oxygen Dissolved in Tissues at the Time of Irradiation as a Factor in Radiotherapy
  The British Journal of Radiology, 1953